Q&A 润达医疗在 2025 年的整体经营情况如何？传统主业和 AI 业务的发展现状是 什么？ 润达医疗 20260114 摘要 润达医疗预计 2026 年传统主业经营反转，AI 业务进展顺利，已与约 160 家大型三甲医院落地合作，并与华为、华鲲振宇合作推出轻量化一 体机智能体，已商业化 15 套。 公司与华为、华鲲振宇合作推出的轻量化一体机智能体已签约约 180 套， 另有 300 多套意向订单，计划半年内推广至全国数百上千家医院，加速 AI 产品临床应用。 润达医疗近期在拉丁美洲和中东签订合同，AI 医疗产品成功进入海外市 场，产品在性能和成本方面均具优势。 公司通过 To B To C 模式布局 C 端市场，与华西医院、天津泰心医院、 中国抗癌协会等合作，针对慢病患者、高频就医人群开发 C 端产品，提 升品牌力。 医院对 AI 服务器及大模型 Agent 的需求集中在临床提质增效、科研创 新和患者就医服务体验提升三个方向，不同科室可能需要单独配置 AI 设 备。 医院对 AI 医疗产品的需求主要集中在诊前预问诊导诊、诊后患者教育管 理和健康管理等方面，基层医院、社区医院需求更为迫切。 公司通过与华西、 ...

Summary of Conference Call on AI in Healthcare - DeepSeek Industry Overview - The application of AI in the healthcare sector is increasingly widespread, particularly in areas such as image recognition, Clinical Decision Support Systems (CDSS), and intelligent triage [1][2] - Collaboration between Ruijin Hospital and Huawei has led to the development of an open-source large model that significantly enhances pathological recognition capabilities, which has been adopted by multiple hospitals to alleviate the shortage of pathologists [1][2] Key Insights and Arguments - AI technology has shown remarkable progress in medical imaging, especially in chest X-rays, CT scans, MRIs, and angiography, with significant efficiency in identifying lung nodules during the pandemic [2] - The integration of AI in rehabilitation robotics is a promising area, particularly in community hospitals, with companies like Fourier Intelligence making substantial advancements [2][3] - The current AI systems in hospitals are primarily provided by external vendors, while hospitals supply the necessary hardware, such as Haiguang CPUs and Huawei 910B integrated machines [5] - AI accounts for approximately 1% of total healthcare IT spending, with one-third of that allocated to AI solutions [6] Emerging Trends - Personal health applications, both domestically (e.g., Ant Financial's Aifuku) and internationally (e.g., OpenAI Health), are rapidly developing, focusing on managing patient data through apps in collaboration with healthcare professionals [7][8] - Future data integration efforts may focus on chronic diseases like diabetes, with third-party platforms facilitating data sharing and utilization [9] Data Management and Integration - Current efforts in hospital data management are being spearheaded by local health authorities, with projects in the planning stages to organize and potentially trade data assets [10][11] - Although no hospital has fully established a comprehensive data management system yet, pilot projects are underway to explore data asset trading [11] Competitive Dynamics - The relationship between public hospitals, third-party companies, and large enterprises is evolving, with commercial entities potentially addressing service limitations imposed by insurance reimbursement standards [12] - The demand for rehabilitation services is high in aging cities like Shanghai, where the shortage of rehabilitation physicians and expensive equipment presents challenges [3][14] Future Prospects - The acceptance of large models in hospitals has increased significantly, with AI technology becoming a standard component in various healthcare IT projects [4] - The integration of AI in hospital management is expected to enhance operational efficiency and improve service quality [4] - The market for rehabilitation robots is expected to diversify in terms of payment models, with potential for private institutions to adopt service fees or insurance payments [17] Conclusion - The healthcare industry is on the brink of a significant transformation driven by AI technologies, with ongoing developments in data management, rehabilitation robotics, and personalized health applications paving the way for improved patient care and operational efficiency [1][2][3][4][5][6][7][8][9][10][11][12][14][17]

Summary of Ark Health Conference Call Company Overview - Ark Health has established a comprehensive chronic disease management service system that integrates AI technology with medical services, chronic disease management, patient education, and pharmaceutical services, extending to patients' homes to optimize medical resource allocation and address challenges in offline medical visits and medication procurement [2][4] Financial Performance - In the first half of 2026, Ark Health achieved a turnaround in net profit, reporting over 10 million yuan in profit, with adjusted net profit reaching 17 million yuan, a year-on-year increase of 16.8%. Revenue approached 1.5 billion yuan, reflecting a 13% year-on-year growth, with expectations for over 25% revenue growth for the entire year [2][4] Business Model and Strategy - The core business model focuses on online doctor-patient interaction through an internet hospital platform after initial offline consultations, utilizing AI for electronic prescriptions and drug delivery. The company emphasizes prescription drug sales, with over 80% of revenue derived from prescription drugs, more than half of which are original imported drugs [2][6] - Ark Health collaborates with Tencent Health to leverage Tencent's large model for medical applications, expanding service coverage and achieving mutual benefits [5][8] Market Potential - The platform has approximately 52.8 million registered users, with over 11.9 million monthly active users. The chronic disease management market is projected to reach nearly 500 billion yuan by 2030, indicating significant growth potential for the company [3][11] Competitive Advantages - The platform boasts around 230,000 doctors, with 60% from top-tier hospitals and 40% at the deputy chief physician level or above, providing a competitive edge in medical resources compared to broader internet healthcare competitors [7] - Ark Health's focus on a familiar doctor-patient relationship model has few competitors, enhancing its market position [7] Future Outlook - The company plans to introduce new AI tools to enhance chronic disease management and improve doctor-patient efficiency. It aims to solidify its existing business segments: internet hospitals, online pharmacies, and marketing services, while also exploring new product opportunities in commercial insurance and long-term care insurance [13] - Financially, the company anticipates growth rates in the coming years to exceed those of the current year, with expectations for continued high growth in the second half of the year [13] Additional Insights - The introduction of weight loss drugs as a new category had a minimal impact on revenue proportions, but the platform's strong trust relationship with patients resulted in better retention, conversion rates, and average transaction values compared to broader competitors [12] - The launch of two large models, "Xinshi" and "Xinjie," focuses on core medical scenarios, emphasizing the importance of practical application in the AI medical field [9]

Group 1: Industry Impact - The U.S. White House announced a 25% import tariff on certain semiconductors and related products starting January 15, aiming to encourage domestic chip manufacturing and reduce reliance on foreign suppliers, particularly from China [1] - The Ministry of Finance in China is promoting a coordinated fiscal and financial policy to boost domestic demand, emphasizing the need for streamlined processes and effective policy implementation [3] - The Chinese government extended the tax refund policy for residents purchasing new homes after selling their previous ones, indicating a potential end to the real estate adjustment cycle by 2026, with a clear trend towards "good housing" [4] Group 2: Market Signals - Multiple signals of market cooling were observed, including significant sell orders on major stocks and regulatory actions by the Shanghai Stock Exchange to mitigate risks, suggesting a focus on long-term market health rather than immediate suppression [2] - Analysts from various institutions expressed a generally positive outlook for the market, with expectations of good liquidity leading up to the Spring Festival and potential structural opportunities as the market continues to reach new highs [7][8][9] Group 3: Sector Developments - The precious metals market is experiencing significant price increases, with silver surpassing $92, indicating strong demand and potential investment opportunities in related sectors [10] - The automotive sector is set to accelerate in smart technology adoption, with Shanghai's action plan for intelligent driving expected to position L3 autonomous driving as a key investment theme by 2026 [11] - The AI healthcare sector is poised for rapid growth, driven by advancements in medical devices and supportive government policies, suggesting a promising landscape for investment in AI applications [12]

近日，在一场公开的行业论坛上，国家传染病医学中心（上海）主任张文宏因"拒绝将AI引入其所在医 院的电子病历系统"的发言被推上风口浪尖。 其次，他认为医院电子病历系统引入AI后，医生的培训过程将明显改变。原本需要经过实习医生、住 院医师、高职级医生的历练，现在借助AI便能创造"捷径"，直接生成与资深医生类似的诊断结论。 这两种情况共同作用，小则打乱了医生的学习进程，大则无中生出医疗隐患。 站在临床的角度，张文宏对于AI的审慎立场可以理解，毕竟医疗安全关乎患者生命。同时，孕育AI的 数据本身就来源于这些资深医生长年累月的积累，他们的判断与鉴别能力在绝大多数情况下比AI更准 确。 但在现实之中，三级医院的医生长期面临海量患者的诊疗压力。相比追求绝对的精准，他们更需要的是 在决策过程中做好"准确与效率的平衡"。 如今优质医疗资源缺失仍是常态，有机会优化诊疗平衡的AI工具，或许不应该被简单地排斥在医生的 工作流之外。 最受欢迎的医疗AI工具？ 过去一年中，《健闻咨询》陆续访谈了30多位经常在工作中使用医疗AI工具的三级医院医生。在回 答"什么样的AI工具最好用"时，超过70%医生选择了和电子病历相关的医疗AI应用。 广 ...

（来源：湖州日报） 转自：湖州日报 文/记者 徐震 App上"AI问诊"，"AI陪诊员"引导入院，"AI听诊器"筛选病情，有AI功能的达芬奇手术机器人辅助医 生……眼下，不少市民发现，AI医疗越来越多出现在生活场景中。 但不少疑问也随之而来："能解决多少实际需求？""是助手还是医生？""基层医院如何能用上？"……背 后，既有对AI医疗专业与安全的担忧，也有对其满足实际和基层需求的期盼。 2025年10月，国家卫生健康委等五部门联合印发的《关于促进和规范"人工智能+医疗卫生"应用发展的 实施意见》（以下简称《实施意见》），就基于"解决真实需求""更多篇幅放在基层和预防""坚持人工 智能赋能而不替代"等考虑，这与当下大众的关切一致。 日前，记者走访了我市多家医疗机构，探访AI医疗的现状与未来。 一问 能解决多少实际需求？ 一直被失眠和焦虑困扰的市民张博，最近点开"安诊儿"App，向市第三人民医院首席精神科专家沈鑫华 的分身"AI医生"进行了咨询。"AI医生"在询问了"失眠特征""生活影响"等情况后，给出了睡前放松活 动、记录"压力日记"等建议。 "这样的'AI问诊'回复很有针对性，也让我去医院就诊做了心理准备。" ...

Group 1 - The "Atomic Energy Law of the People's Republic of China" officially took effect on January 15, marking the first fundamental law in China's nuclear energy sector [1] - The second China eVTOL Innovation Development Conference was held in Shanghai from January 15 to 16 [1] - Huibo's controlling shareholder will change to Baile Equipment Group, with the actual controller changing to the State-owned Assets Supervision and Administration Commission of Tianjin [1] Group 2 - The Ministry of Finance, the State Taxation Administration, and the Ministry of Housing and Urban-Rural Development announced the extension of personal income tax policies supporting residents' housing purchases from January 1, 2026, to December 31, 2027 [1] - A joint meeting was held by the Ministry of Industry and Information Technology, the National Development and Reform Commission, and the State Administration for Market Regulation to resist disorderly "price wars" in the new energy vehicle industry [1] Group 3 - The Hainan Free Trade Port has seen 585,000 people engage in duty-free shopping, with a total amount of 3.89 billion yuan, representing year-on-year increases of 32.4% and 49.6% respectively [2] - The Ministry of Finance plans to issue 400 billion yuan of 91-day discount treasury bonds [2] - A guideline was issued to enhance the collaborative development of meteorological services in health and wellness, aiming for a comprehensive system by 2030 [2] Group 4 - IDC reported that Apple ranked first in China's smartphone market in Q4 2025, followed by vivo, OPPO, Huawei, and a tie between Honor and Xiaomi in fifth place [3] - Honor's global shipment volume exceeded 71 million units for the first time, with a year-on-year growth of approximately 55% in overseas shipments [3] Group 5 - Shanghai released the "Mosu Zhixing" action plan to accelerate the advancement of automotive intelligence, aiming for large-scale application of high-level autonomous driving by 2027 [4] - East Asia Securities predicts that the penetration of new energy vehicles, exports, and intelligent high-end development will be structural highlights in the automotive market in 2026 [4] Group 6 - Meta plans to double the production capacity of AI glasses to 20 million units by the end of 2026, driven by steady sales growth [5] - The global AR market is expected to enter a rapid development phase due to AI technology, supply chain optimization, and the entry of major players [5] Group 7 - Google launched the new MedGemma 1.5 AI medical model, enhancing capabilities in medical imaging and text processing [6] - AI in healthcare shows strong potential in improving medical device functions and assisting clinical decision-making [6] Group 8 - Huazhong University of Science and Technology's subsidiary plans to establish a semiconductor device research and production base with a total investment of 1 billion yuan [7] - Colorful Technology plans to issue convertible bonds to raise up to 1.46 billion yuan for AI-related projects [7] Group 9 - Four-dimensional Map expects revenue of 4.06 billion to 4.34 billion yuan in 2025, with a year-on-year growth of 15.42% to 23.50% [8] - The company anticipates a significant increase in revenue from its data compliance business in 2025 [8] Group 10 - Institutional investors net purchased 516 million yuan of Guangxun Technology, highlighting its strong market position in optical communication [9] - Jiarun Technology received a net purchase of 298 million yuan, focusing on expanding its network information security capabilities [10] Group 11 - Equity ETFs saw a net subscription of over 47 billion yuan in three trading days, with significant interest in thematic ETFs [11] - Institutional investors also net purchased several companies, indicating strong market confidence [11] Group 12 - Weili Transmission is advancing its wind power gearbox smart factory, which is expected to significantly increase revenue and improve profit margins [12] - The global wind energy market is projected to drive demand for core components like wind power gearboxes [12] Group 13 - Ouma Software is building a comprehensive AI ecosystem in the examination and assessment field, enhancing its core technologies [13] - The company aims to integrate AI into various examination processes, establishing a competitive edge and growth potential [13]

Industry News - The insurance fund long-term investment reform pilot has welcomed additional capital, with the Honghu Fund Phase 3 raising 40 billion yuan, bringing the total number of funds in the series to five [5] - The Ministry of Finance, the State Administration of Taxation, and the Ministry of Housing and Urban-Rural Development announced the continuation of personal income tax policies supporting residents' housing purchases, providing tax refunds for taxpayers who sell their homes and buy new ones within one year [5] Company News - Haohan Deep announced that its AI application business in the financial sector has not yet generated revenue [9] - WISCO Development released a major asset restructuring plan, intending to swap its main assets and liabilities with 100% equity of WISCO Mining and Luzhong Mining, and has resumed trading [9] - Unisoc disclosed a restructuring plan to acquire 100% equity of Ruineng Semiconductor, with its stock and convertible bonds resuming trading [9] - Dike Co. announced an expected net loss of 200 million to 300 million yuan for 2025, primarily due to significant fair value losses related to silver futures and leasing [9] - Hu Silicon Industry released a performance forecast, expecting a net loss of 1.28 billion to 1.53 billion yuan for 2025, attributed to a decline in the price of 300mm semiconductor silicon wafers [9] - CITIC Securities announced a net profit of 30.1 billion yuan for 2025, representing a year-on-year increase of 38.46% [9] - Tian Di Online reported that its subsidiary is involved in a contract fraud case amounting to 55.09 million yuan and has reported to the police [9] - Jiamei Packaging released a performance forecast, expecting a year-on-year decrease in net profit of 43% to 53% for 2025 [9] - Jinyu Group announced a performance forecast, expecting a net loss of 900 million to 1.2 billion yuan for 2025 [9] - Zhi Te New Materials stated on an interactive platform that it has no AI applications or quantum technology business and has not generated related revenue [9]

Wind数据显示，截至2026年1月14日，全市场业绩位居前三十的产品中，医疗主题基金几乎占据半壁江山，包括银 河康乐混合、招商前沿医疗保健、金鹰医疗健康、万家健康产业等一批新年内绩优产品，不少基金开年两周时间 的收益率已远超去年全年业绩。例如，银河基金旗下的银河康乐混合2025年的收益率为17.05%，该产品开年两周 的收益率已达到24%，万家基金旗下的万家健康产业基金2026年开年后两周迅速获取26.55%的收益率。 为何这些医疗主题基金2026年开年突然发力？深圳地区一位公募研究部人士告诉记者，核心原因是这些医疗主题 基金大部分并非创新药主题基金，虽然这些产品的行业主题名称极为相似，但它们的持仓重点并非创新药，而是 偏重医疗科技。 证券时报记者 王小芊 2026年开年仅半个月，一批踏空2025年行情的另类医疗主题基金，就迎来业绩红包，多只产品两周收益远超去年 全年。 证券时报记者注意到，这波医疗主题基金行情的核心并非创新药，而是重仓AI医疗科技方向的基金。这些产品大 多数在去年踏空医药赛道行情，但是凭借AI应用的叙事延伸到医疗互联网科技赛道，不少基金经理今年仅凭借少 数几只个股的腾飞就带动了整只产品净值 ...

Core Viewpoint - The article discusses the evolving landscape of AI in healthcare, emphasizing the need for AI technologies to integrate into clinical workflows and payment systems to create sustainable revenue streams and improve efficiency [5][38]. Group 1: AI in Drug Development and Research - AI is transitioning from a standalone tool to an integral part of the drug development pipeline, focusing on producing clinically viable molecules and breaking down uncertainties through milestone-based collaborations [8]. - Companies like Recursion Pharma are leveraging AI to transform computational power and data into quantifiable assets, with significant investments such as a $50 million partnership with NVIDIA [9][10]. - Insitro exemplifies a transactional approach by embedding machine learning directly into drug discovery, with collaborations that include milestone payments to manage research timelines [12]. Group 2: AI in Medical Devices and Imaging - The competition in AI medical devices is shifting from algorithm strength to the integration of algorithms into clinical pathways and reimbursement systems, aiming to shorten decision-making and operational chains for physicians [13]. - Companies like HeartFlow and Butterfly Network are focusing on embedding AI into clinical decision-making processes, with HeartFlow's products receiving regulatory approval and Butterfly's portable ultrasound devices emphasizing software and service models [15][17]. Group 3: AI in Diagnostics and Precision Medicine - AI diagnostics and precision medicine are the largest segments, connecting the testing needs of doctors and patients with pharmaceutical companies' demands for real-world data and companion diagnostics [18]. - Tempus, a leader in this space, reported a total contract value exceeding $1.1 billion and a revenue growth of approximately 31% in data and application services [20]. Group 4: AI in Digital Health and Clinical Workflows - The digital health market is evolving towards quantifiable time-saving and cost-control solutions, with products that integrate into daily workflows being more likely to secure budgets [23]. - Companies like Abridge and Omada Health are focusing on automating clinical documentation and chronic disease management, respectively, to enhance operational efficiency and patient engagement [26]. Group 5: AI Infrastructure and Medical IT Platforms - Companies that control distribution channels and have established customer relationships are positioned to leverage AI as a tool for revenue growth, rather than starting from scratch [28]. - Innovaccer and Modernizing Medicine are examples of platforms that enhance patient access and workflow efficiency, indicating that administrative and process efficiency is often the first area where AI is adopted [31]. Group 6: AI in Payment and Medical Services - The payment and medical services sector is focused on reducing errors and management costs, with a strong emphasis on auditability and traceability of AI solutions [32]. - Companies like Labcorp are integrating AI into their operational frameworks to enhance efficiency and quality control, indicating that AI is viewed as an operational upgrade rather than a standalone product [35].